Federation des caisses Desjardins du Quebec’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.8M | Sell |
205,779
-3,020
| -1% | -$670K | 0.16% | 107 |
|
|
2025
Q4 | $47.7M | Buy |
208,799
+44,628
| +27% | +$10.2M | 0.18% | 98 |
|
|
2025
Q3 | $38M | Sell |
164,171
-2,061
| -1% | -$420K | 0.15% | 115 |
|
|
2025
Q2 | $30.9M | Buy |
166,232
+723
| +0.4% | +$134K | 0.14% | 129 |
|
|
2025
Q1 | $34.7M | Buy |
165,509
+15,105
| +10% | +$2.94M | 0.17% | 111 |
|
|
2024
Q4 | $26.7M | Sell |
150,404
-83,802
| -36% | -$15.4M | 0.14% | 130 |
|
|
2024
Q3 | $46.2M | Buy |
234,206
+776
| +0.3% | +$145K | 0.23% | 72 |
|
|
2024
Q2 | $40M | Buy |
233,430
+35,831
| +18% | +$5.94M | 0.21% | 81 |
|
|
2024
Q1 | $35.4M | Buy |
197,599
+9,630
| +5% | +$1.66M | 0.26% | 85 |
|
|
2023
Q4 | $29.1M | Buy |
187,969
+1,128
| +0.6% | +$164K | 0.27% | 82 |
|
|
2023
Q3 | $27.9M | Buy |
186,841
+8,309
| +5% | +$1.22M | 0.29% | 76 |
|
|
2023
Q2 | $24.1M | Sell |
178,532
-10,358
| -5% | -$1.52M | 0.24% | 95 |
|
|
2023
Q1 | $30.1M | Buy |
188,890
+28,174
| +18% | +$4.31M | 0.33% | 65 |
|
|
2022
Q4 | $26M | Sell |
160,716
-39,032
| -20% | -$5.98M | 0.31% | 77 |
|
|
2022
Q3 | $26.8M | Buy |
199,748
+2,094
| +1% | +$300K | 0.32% | 72 |
|
|
2022
Q2 | $30.3M | Sell |
197,654
-3,961
| -2% | -$605K | 0.34% | 67 |
|
|
2022
Q1 | $32.7M | Sell |
201,615
-46,876
| -19% | -$6.81M | 0.32% | 71 |
|
|
2021
Q4 | $33.6M | Buy |
248,491
+4,491
| +2% | +$531K | 0.33% | 67 |
|
|
2021
Q3 | $26.3M | Buy |
244,000
+14,155
| +6% | +$1.62M | 0.27% | 73 |
|
|
2021
Q2 | $25.9M | Buy |
229,845
+2,073
| +0.9% | +$233K | 0.26% | 74 |
|
|
2021
Q1 | $24.7M | Buy |
227,772
+17,751
| +8% | +$1.9M | 0.27% | 73 |
|
|
2020
Q4 | $22.5M | Buy |
210,021
+36,697
| +21% | +$3.53M | 0.27% | 74 |
|
|
2020
Q3 | $15.2M | Buy |
173,324
+7,134
| +4% | +$672K | 0.21% | 97 |
|
|
2020
Q2 | $16.3M | Buy |
166,190
+18,966
| +13% | +$1.67M | 0.24% | 85 |
|
|
2020
Q1 | $11.2M | Sell |
147,224
-4,632
| -3% | -$395K | 0.2% | 92 |
|
|
2019
Q4 | $13.4M | Sell |
151,856
-697
| -0.5% | -$57.9K | 0.19% | 91 |
|
|
2019
Q3 | $11.6M | Buy |
152,553
+13,287
| +10% | +$911K | 0.17% | 101 |
|
|
2019
Q2 | $10.1M | Buy |
139,266
+3,289
| +2% | +$259K | 0.15% | 121 |
|
|
2019
Q1 | $11M | Buy |
135,977
+14,190
| +12% | +$1.16M | 0.17% | 111 |
|
|
2018
Q4 | $11.2M | Buy |
121,787
+59,899
| +97% | +$5.27M | 0.19% | 96 |
|
|
2018
Q3 | $5.85M | Sell |
61,888
-2,417
| -4% | -$229K | 0.09% | 199 |
|
|
2018
Q2 | $5.96M | Sell |
64,305
-2,965
| -4% | -$290K | 0.09% | 207 |
|
|
2018
Q1 | $6.37M | Sell |
67,270
-7,456
| -10% | -$819K | 0.1% | 190 |
|
|
2017
Q4 | $7.23M | Buy |
74,726
+5,147
| +7% | +$485K | 0.11% | 179 |
|
|
2017
Q3 | $6.18M | Buy |
69,579
+2,976
| +4% | +$227K | 0.1% | 191 |
|
|
2017
Q2 | $4.83M | Sell |
66,603
-5,957
| -8% | -$400K | 0.08% | 216 |
|
|
2017
Q1 | $4.73M | Buy |
+72,560
| New | +$4.56M | 0.09% | 198 |
|
Other funds holding ABBV
VCM
VPM
Federation des caisses Desjardins du Quebec's ABBV Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec reduced its AbbVie (ABBV) stake by 1.4% in Q1 2026, selling an estimated $670K and leaving 205,779 shares worth $44.8M. The position accounts for 0.16% of the portfolio, ranked #107.
Federation des caisses Desjardins du Quebec first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $47.7M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 205,779 shares of AbbVie worth $44.8M as of Q1 2026.
- Federation des caisses Desjardins du Quebec sold 3,020 AbbVie shares in Q1 2026, an estimated $670K.
- AbbVie made up 0.16% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #107 holding.
- Federation des caisses Desjardins du Quebec first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Federation des caisses Desjardins du Quebec's AbbVie position peaked at $47.7M in Q4 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.